Here, using the novel reduced graphene oxide/polydopamine‐molecularly imprinted polymer (rGO/PDA‐MIP) as the probe layer, a robust electrochemical sensing platform is demonstrated for the ultrasensitive detection of glial fibrillary acidic protein (GFAP), a biomarker for a range of neurological diseases. This evidence concerns the gene GFAP and nervous system disorder.